Neurocrine Biosciences In... (NBIX)
NASDAQ: NBIX
· Real-Time Price · USD
132.85
1.54 (1.17%)
At close: Aug 15, 2025, 3:59 PM
132.90
0.04%
After-hours: Aug 15, 2025, 04:34 PM EDT
Neurocrine Biosciences Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 348.3M | 305.8M | 341.3M | 385.9M | 339.2M | 369.7M | 249.7M | 191M | 176.4M | 64M | 154.5M | 58.2M | 12.2M | 71.4M | 89.6M | 444.8M | 364.7M | 402M |
Depreciation & Amortization | 28.5M | 28.5M | 27.1M | 25.7M | 24.7M | 22.5M | 21.3M | 20M | 18.5M | 17.3M | 15.6M | 14.2M | 13M | 11.7M | 10.9M | 10.1M | 9.5M | 9M |
Stock-Based Compensation | 213.5M | 203.8M | 195.5M | 167.2M | 173.5M | 198.9M | 194.3M | 199.7M | 195M | 176M | 173.1M | 165.2M | 159.2M | 138.3M | 134.2M | 119.6M | 109.2M | 110.1M |
Other Working Capital | 85.1M | 81.2M | 78.4M | 26.1M | -6M | 69.3M | 47.8M | -77.3M | -44.9M | -107.8M | -94.2M | -16M | -24.7M | -29.4M | -17M | -43.7M | -44.8M | -34.8M |
Other Non-Cash Items | -4.4M | 240.7M | 399.6M | 361.8M | 384.9M | 126.6M | -46.9M | -17.9M | -61.9M | -18.6M | -32.9M | -54.3M | -29.4M | -24M | 800K | 59.2M | 51M | 49.4M |
Deferred Income Tax | -117.3M | -121.2M | -123.1M | -71.2M | -40.5M | -40.7M | -56.7M | -63.8M | -50.6M | -12.2M | 19.1M | 900K | -2.4M | 10.2M | 4.3M | -301.7M | -300.4M | -321.2M |
Change in Working Capital | 98.7M | 12.4M | -19.2M | -167.2M | -125.6M | 54.1M | 28.2M | 80.4M | 18.8M | -49.2M | -67.4M | -61M | -66.4M | -78.9M | 16.7M | 9.2M | 27.9M | 28.3M |
Operating Cash Flow | 567.3M | 529.9M | 595.4M | 476.4M | 530.4M | 645.4M | 389.9M | 409.4M | 296.2M | 254.7M | 339.4M | 200.6M | 163.6M | 128.7M | 256.5M | 341.2M | 261.9M | 277.6M |
Capital Expenditures | -38.6M | -37.7M | -38.2M | -36.3M | -35.8M | -31M | -28.3M | -24.7M | -15.4M | -17.4M | -16.5M | -23.6M | -31M | -26.5M | -23.4M | -19M | -13.7M | -14.1M |
Cash Acquisitions | n/a | n/a | n/a | 5.4M | 95.1M | 101.9M | 99.7M | 51.6M | -39.8M | -46.6M | -56.6M | -13.9M | -12.2M | -12.2M | -700K | -700K | -700K | -700K |
Purchase of Investments | -1.13B | -1.01B | -1.06B | -1.23B | -1.36B | -1.49B | -1.41B | -1.16B | -928.8M | -665.9M | -628.9M | -537M | -683M | -911.5M | -804.7M | -999.6M | -830M | -657.2M |
Sales Maturities Of Investments | 1.11B | 989.3M | 967.5M | 1.01B | 1.02B | 1.04B | 972.4M | 843.8M | 642M | 538.4M | 511M | 522.8M | 611.3M | 713.1M | 697.9M | 717M | 693.5M | 705.3M |
Other Investing Acitivies | n/a | -16.6M | -60.4M | -65.8M | -155.5M | -145.7M | -99.7M | -165.4M | -74M | -27M | -17M | 54.1M | 52.4M | 12.2M | 700K | 700K | 700K | 700K |
Investing Cash Flow | -58.4M | -57.6M | -126.8M | -260.3M | -382.3M | -480M | -467.1M | -380.9M | -344.9M | -187.6M | -177.1M | -37.8M | -102.7M | -224.9M | -130.2M | -301.6M | -150.2M | 34M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -279M | -279M | -279M | -279M | n/a | -100K | -100K | -100K | -100K |
Common Stock Repurchased | -167.7M | -150M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -381.5M | -690.3M | -502.5M | -177.1M | -184.7M | 127M | 65.3M | 54.5M | 47.1M | 46.8M | 38.6M | 15.8M | 11.9M | 12.3M | 27.5M | -161.2M | -168.7M | -171.7M |
Financial Cash Flow | -384.8M | -674.5M | -486.7M | -161.3M | -168.9M | 127M | 65.3M | 54.5M | 47.1M | -232.2M | -234.3M | -257.1M | -261M | 18.4M | 27.4M | -153.8M | -158.8M | -146M |
Net Cash Flow | 124.3M | -202.2M | -18.1M | 55.4M | -20.5M | 292.7M | -11.6M | 81.7M | -2.9M | -166.4M | -73.3M | -94.3M | -200.1M | -77.8M | 153.7M | -114.2M | -47.1M | 165.6M |
Free Cash Flow | 528.7M | 492.2M | 557.2M | 440.1M | 494.6M | 614.4M | 361.6M | 384.7M | 280.8M | 237.3M | 322.9M | 177M | 132.6M | 102.2M | 233.1M | 322.2M | 248.2M | 263.5M |